 |
 |
LONDON: Glaxo Invests In New Medical Imaging Centre Tue 16 March, 2004 09:02 LONDON (Reuters) - GlaxoSmithKline, Europe's biggest drugmaker, says it is contributing 46 million pounds to a new imaging centre that could help speed development of new medicines. GSK GSK.L is collaborating with Imperial College London on the project, which will be built alongside Hammersmith Hospital in west London at a total cost of 76 million pounds. The investment reflects the growing importance of magnetic resonance imaging (MRI) and positron emission tomography (PET) in plotting the course of diseases such as cancer, stroke, Parkinson's, Alzheimer's and multiple sclerosis. MRIs use magnetic fields and radio-frequency waves to produce three-dimensional images of tissue in the body, while PET involves a radioactive tracer that can pick up increased metabolic activity found in tumours. Richard Sykes, rector of Imperial and a former chairman of GSK, said the 10-year research agreement was one of the world's largest industry-university collaborations and showed that corporate-academic links could deliver significant results. The government wants to promote more such collaborations in future. SOURCE: Reuters, UK http://tinyurl.com/324xy * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn